Find XO: Insights for AI Startups' Global Leap (venturesquare.net)

- Sixsense and J&P Medi are accelerating their overseas expansion by being selected for Y Combinator's Summer 2026 batch and the Unicorn Bridge program. - While the schedules for batches and support programs move quickly, the pace at which manufacturing sites and clinical trials are adopted do not move at the same rhythm. - The variable that can advance the timetable is the speed of collecting data and proving efficiency on site rather than just prior information. - Participating in the programs should be viewed not as the completion of overseas expansion but as the start of validation.